Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough

ClinicalTrials.gov ID: NCT05392192

Public ClinicalTrials.gov record NCT05392192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 3:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover, Phase 2 Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of ADX-629 Administered Orally to Subjects With Chronic Cough

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover, Phase 2 Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of ADX-629 Administered Orally to Subjects with Chronic Cough

Study identification

NCT ID
NCT05392192
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aldeyra Therapeutics, Inc.
Industry
Enrollment
51 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 7, 2022 (Actual)
Primary completion
Apr 13, 2023 (Actual)
Completion
Apr 13, 2023 (Actual)
Last update posted
Feb 28, 2025

2022 – 2023

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Allergy Associates Medical Group, Inc. San Diego California 92108 —
Allergy & Asthma Associates of Santa Clara Valley Research Center San Jose California 95117 —
Cano Research - Hollywood Hollywood Florida 33024 —
Advanced Pulmonary Research Institute Loxahatchee Groves Florida 33470 —
Florida Pulmonary Research Institute LLC Winter Park Florida 32789 —
ClinCept Columbus Georgia 31904 —
Mayo Clinic Pulmonary Clinic Research Unit Rochester Minnesota 55901 —
Mount Sinai New York New York 10003 —
Charlotte Lung & Health/American Health Research Charlotte North Carolina 28277 —
Bernstein Clinical Research Center, LLC Cincinnati Ohio 45236 —
Vital Prospects Clinical Research Tulsa Oklahoma 74136 —
Northwest Research Center Portland Oregon 97202 —
Clinical Research of Rock Hill Rock Hill South Carolina 29732 —
Pharmaceutical Research and Consulting Inc. Dallas Texas 72531 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05392192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05392192 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →